A man in lab coat sitting at lab bench looking at a small stoppered beaker.
Cancer Researcher Donald Pinkel Dies at Age 95
Unsatisfied by how treatments for childhood leukemia failed to prevent the disease’s return, Pinkel combined them all—and virtually cured the disease.
Cancer Researcher Donald Pinkel Dies at Age 95
Cancer Researcher Donald Pinkel Dies at Age 95

Unsatisfied by how treatments for childhood leukemia failed to prevent the disease’s return, Pinkel combined them all—and virtually cured the disease.

Unsatisfied by how treatments for childhood leukemia failed to prevent the disease’s return, Pinkel combined them all—and virtually cured the disease.

blood cancer
Artist's rendition of a yellow CAR T cell near a red cancer cell surrounded by red blood cells.
Ten Years On, CAR T Cell Recipient Is Still Cancer-Free
Jef Akst | Feb 3, 2022
First, the genetically engineered cells became CD8+ killer T cells that wiped out his leukemia. Then they transformed into a stable population of CD4+ helper T cells that continue to circulate in his body.
streaks of blue and green from a fluorescent chromosome mapping technique
Optical Genome Mapping Works Well in Detecting Cancer Risk
Marcus A. Banks | Jul 22, 2021
The relatively new technique for visually detecting chromosomal variants associated with disease risk performs at least as well as more established techniques in two recent studies.
cancer blood hematologic leukemia solid tumor covid-19 sars-cov-2 coronavirus pandemic mortality t cell b cd8+ cd4+ immunology chemotherapy
COVID-19 More Deadly with Blood than Solid Cancer: Study
Marcus A. Banks | Feb 16, 2021
Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.
Emil Freireich, cancer, leukemia, platelets, blood, chemotherapy, University of Texas MD Anderson Cancer Center
Pioneering Cancer Researcher Emil Freireich Dies at 93
Asher Jones | Feb 5, 2021
The oncologist developed lifesaving childhood leukemia treatments and revolutionized chemotherapy.
Genetic Screens Provide Clues About Prognosis, Risk of Second Cancer
Shawna Williams | Apr 1, 2018
Mutations in the TP53 gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.
Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
Catherine Offord | Dec 17, 2017
More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers. 
Vitamin C Depletion Accelerates Leukemia in Mice
Aggie Mika | Aug 21, 2017
High levels of vitamin C absorbed by blood-forming stem cells are important for their normal development.